Literature DB >> 21835799

Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility.

Monique A Morrison1, Richard J Morreale, Shailaja Akunuru, Matthew Kofron, Yi Zheng, Susanne I Wells.   

Abstract

Expression of the high-risk human papillomavirus (HPV) E6 and E7 oncogenes is essential for the initiation and maintenance of cervical cancer. The repression of both was previously shown to result in activation of their respective tumor suppressor targets, p53 and pRb, and subsequent senescence induction in cervical cancer cells. Consequently, viral oncogene suppression is a promising approach for the treatment of HPV-positive tumors. One well-established method of E6/E7 repression involves the reexpression of the viral E2 protein which is usually deleted in HPV-positive cancer cells. Here, we show that, surprisingly, bovine papillomavirus type 1 (BPV1) E2 but not RNA interference-mediated E6/E7 repression in HPV-positive cervical cancer cells stimulates cellular motility and invasion. Migration correlated with the dynamic formation of cellular protrusions and was dependent upon cell-to-cell contact. While E2-expressing migratory cells were senescent, migration was not a general feature of cellular senescence or cell cycle arrest and was specifically observed in HPV-positive cervical cancer cells. Interestingly, E2-expressing cells not only were themselves motile but also conferred increased motility to admixed HeLa cervical cancer cells. Together, our data suggest that repression of the viral oncogenes by E2 stimulates the motility of E6/E7-targeted cells as well as adjacent nontargeted cancer cells, thus raising the possibility that E2 expression may unfavorably increase the local invasiveness of HPV-positive tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835799      PMCID: PMC3187478          DOI: 10.1128/JVI.05126-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA.

Authors:  M von Knebel Doeberitz; C Rittmüller; H zur Hausen; M Dürst
Journal:  Int J Cancer       Date:  1992-07-09       Impact factor: 7.396

2.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

3.  Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence.

Authors:  Kimberly Johung; Edward C Goodwin; Daniel DiMaio
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

4.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

Authors:  M Scheffner; B A Werness; J M Huibregtse; A J Levine; P M Howley
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

5.  Changes in the migratory ability of human lung and skin fibroblasts during in vitro aging and in vivo cellular senescence.

Authors:  H Kondo; Y Yonezawa
Journal:  Mech Ageing Dev       Date:  1992-05       Impact factor: 5.432

6.  In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes.

Authors:  T M Tan; R C Ting
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

7.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

Authors:  M Scheffner; J M Huibregtse; R D Vierstra; P M Howley
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

8.  Telomerase activation by the E6 gene product of human papillomavirus type 16.

Authors:  A J Klingelhutz; S A Foster; J K McDougall
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

9.  Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.

Authors:  Jayanthi S Lea; Noriaki Sunaga; Mitsuo Sato; Geetha Kalahasti; David S Miller; John D Minna; Carolyn Y Muller
Journal:  Reprod Sci       Date:  2007-01       Impact factor: 3.060

10.  Suppression of cellular proliferation by the papillomavirus E2 protein.

Authors:  J J Dowhanick; A A McBride; P M Howley
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  7 in total

1.  Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples.

Authors:  Naureen Ehsan Ilahi; Shoaib Naiyar Hashmi; Sobia Anwar; Sheeba Murad
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-30       Impact factor: 4.553

2.  HPV16 E2-mediated potentiation of NF-κB activation induced by TNF-α involves parallel activation of STAT3 with a reduction in E2-induced apoptosis.

Authors:  Devan Prabhavathy; Bandaru Niranjana Prabhakar; Devarajan Karunagaran
Journal:  Mol Cell Biochem       Date:  2014-05-16       Impact factor: 3.396

3.  Photon-induced cell migration and integrin expression promoted by DNA integration of HPV16 genome.

Authors:  Stefan Rieken; Florian Simon; Daniel Habermehl; Jan Oliver Dittmar; Stephanie E Combs; Klaus Weber; Jürgen Debus; Katja Lindel
Journal:  Strahlenther Onkol       Date:  2014-03-19       Impact factor: 3.621

4.  Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.

Authors:  O Andreas Karlsson; Juan Ramirez; Daniel Öberg; Tony Malmqvist; Åke Engström; Maria Friberg; Celestine N Chi; Mikael Widersten; Gilles Travé; Mikael T I Nilsson; Per Jemth
Journal:  Sci Rep       Date:  2015-03-23       Impact factor: 4.379

5.  Regulation of human genome expression and RNA splicing by human papillomavirus 16 E2 protein.

Authors:  Elaine J Gauson; Brad Windle; Mary M Donaldson; Maria M Caffarel; Edward S Dornan; Nicholas Coleman; Pawel Herzyk; Scott C Henderson; Xu Wang; Iain M Morgan
Journal:  Virology       Date:  2014-08-16       Impact factor: 3.616

6.  The role of the globular heads of the C1q receptor in HPV-16 E2-induced human cervical squamous carcinoma cell apoptosis via a mitochondria-dependent pathway.

Authors:  Zheng-lin Chen; Ya-juan Su; Hui-lin Zhang; Ping-qing Gu; Ling-juan Gao
Journal:  J Transl Med       Date:  2014-10-05       Impact factor: 5.531

7.  Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells.

Authors:  Molly L Bristol; Claire D James; Xu Wang; Christian T Fontan; Iain M Morgan
Journal:  mSphere       Date:  2020-03-18       Impact factor: 4.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.